Original Article
Patterns of regional lymph node metastasis predict postoperative overall survival and disease-free survival in locally advanced esophageal squamous cell carcinoma
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1365-1372
.
(31 August 2024)
Risk factors contributing to morbidity associated with feeding tubes placed for esophageal cancer patients undergoing esophagectomy: a single-center retrospective study
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1373-1385
.
(31 August 2024)
Clinical features and risk of multiple primary malignancies after endoscopic treatment in patients with early esophageal squamous cell carcinoma: a retrospective cohort study
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1386-1398
.
(31 August 2024)
Efficacy and safety of camrelizumab combined with chemotherapy in the first-line treatment of advanced gastric cancer: a single-arm, phase II study
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1399-1408
.
(31 August 2024)
Potential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacology
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1409-1430
.
(31 August 2024)
CMTM4 inhibits gastric tumorigenesis and metastasis
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1431-1445
.
(31 August 2024)
Developing a prognostic signature: identifying differentially expressed genes in cardia and non-cardia gastric cancer for immunity and therapeutic sensitivity analysis
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1446-1463
.
(31 August 2024)
Proteome-wide Mendelian randomization and single-cell sequencing analysis identify the association between plasma proteins and gastric cancer
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1464-1474
.
(31 August 2024)
Parkinson’s disease and the risk of gastrointestinal cancers: a two-sample Mendelian randomization study
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1475-1486
.
(31 August 2024)
Cultural and social barriers to hope in gastrointestinal cancer patients
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1487-1496
.
(31 August 2024)
Regorafenib combined with immune checkpoint inhibitors versus regorafenib monotherapy as a late-line treatment for metastatic colorectal cancer: a single-center, retrospective cohort study
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1497-1507
.
(31 August 2024)
The impact of transanal drainage tube on the incidence of anastomotic leakage and small bowel obstruction in radical surgery (Dixon) for rectal cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1508-1518
.
(31 August 2024)
Fruquintinib in metastatic colorectal cancer: a multicenter real-world analysis on efficacy, safety, and predictive and prognostic factors
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1519-1533
.
(31 August 2024)
PD-1 blockade combined with chemotherapy and bevacizumab in DNA mismatch repair-proficient/microsatellite stable colorectal liver metastases
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1534-1544
.
(31 August 2024)
Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1545-1555
.
(31 August 2024)
Association between sleep traits and risk of colorectal cancer: a bidirectional Mendelian randomization study
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1556-1567
.
(31 August 2024)
The benefit of adjuvant chemotherapy in pathological T1–3N0M0 rectal mucinous adenocarcinoma: no improvement survival outcomes based on long-term survival analysis of large population data
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1568-1579
.
(31 August 2024)
Integrated molecular profiling of RAS, BRAF mutations, and mismatch repair status in advanced colorectal carcinoma: insights from gender and tumor laterality
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1580-1591
.
(31 August 2024)
A novel model based on protein post-translational modifications comprising the immune landscape and prediction of colorectal cancer prognosis
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1592-1612
.
(31 August 2024)
Promotion of hepatocellular carcinoma stemness and progression by abnormal spindle-like microcephaly-associated protein via the Wnt/β-catenin pathway
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1613-1626
.
(31 August 2024)
Efficacy and safety of transarterial chemoembolization alone compared to its combination with anlotinib among patients with intermediate or advanced stage hepatocellular carcinoma: a phase II randomized controlled trial
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1627-1635
.
(31 August 2024)
Identification of a lactylation-related gene signature to characterize subtypes of hepatocellular carcinoma using bulk sequencing data
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1636-1646
.
(31 August 2024)
Identification of a prognostic disulfidptosis-related gene signature in hepatocellular cancer
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1647-1656
.
(31 August 2024)
Development and validation of a nomogram to predict cancer-specific survival of patients with large hepatocellular carcinoma accepting surgical resection: a real-world analysis based on the SEER database
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1657-1673
.
(31 August 2024)
NOVA2 regulates the properties of liver cancer stem cells and lenvatinib resistance in hepatocellular carcinoma via the Wnt pathway
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1674-1685
.
(31 August 2024)
The clinical outcomes of patients with vascular invasion after deceased donor liver transplantation
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1686-1697
.
(31 August 2024)
Discontinuation of immune checkpoint inhibitors in hepatocellular carcinoma: a retrospective cohort study
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1698-1711
.
(31 August 2024)
YAP-based nomogram predicts poor prognosis in patients with hepatocellular carcinoma after curative surgery
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1712-1722
.
(31 August 2024)
Liquid-liquid phase separation-related features of PYGB/ACTR3/CCNA2/ITGB1/ATP8A1/RAP1GAP2 predict the prognosis of pancreatic cancer
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1723-1745
.
(31 August 2024)
LDHA as a predictive biomarker and its association with the infiltration of immune cells in pancreatic adenocarcinoma
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1746-1759
.
(31 August 2024)
Analyzing the role of TM4SF1 expression in pancreatic adenocarcinoma: understanding prognostic implications and therapeutic opportunities
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1760-1776
.
(31 August 2024)
Epidemiology, survival and new treatment modalities for intrahepatic cholangiocarcinoma
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1777-1788
.
(31 August 2024)
Pancreatic cancer mortality trends in the United States: how much have we moved the needle?
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1789-1795
.
(31 August 2024)
Sarcomatoid change in combined hepatocellular carcinoma and cholangiocarcinoma as a poor prognostic factor
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1796-1804
.
(31 August 2024)
Combination of neutrophil-to-lymphocyte ratio and serum CA 19-9 as a prognostic factor in pancreatic cancer
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1805-1819
.
(31 August 2024)
Concomitant or antecedent intraductal papillary mucinous neoplasm is not a prognostic factor in resected pancreatic cancer
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1820-1826
.
(31 August 2024)
Laparoscopic distal pancreatectomy for pancreatic cancer: an overview of evaluation and treatment strategies
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1827-1835
.
(31 August 2024)
Single-cell analysis of chemotherapy-resistant microenvironment identifies a chemo-response biomarker for pancreatic cancer
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1836-1846
.
(31 August 2024)
Intra-abdominal temperature variation during hyperthermic intraperitoneal chemotherapy evaluated via computational fluid dynamics modeling
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1847-1860
.
(31 August 2024)
Review Article
Particle therapy in gastrointestinal cancer—a narrative review
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1861-1869
.
(31 August 2024)
The emerging role of FAM46C as a biomarker and therapeutic target in gastric adenocarcinoma
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1870-1879
.
(31 August 2024)
Stereotactic body radiation therapy (SBRT) in patients with hepatocellular cancer—a narrative review and expert opinion
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1880-1892
.
(31 August 2024)
MR-linac based radiation therapy in gastrointestinal cancers: a narrative review
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1893-1907
.
(31 August 2024)
Stereotactic body radiation therapy in non-liver colorectal metastases: a scoping review
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1908-1916
.
(31 August 2024)
Stereotactic body radiation therapy for colorectal cancer liver metastases
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1917-1925
.
(31 August 2024)
Case Report
Laparoscopic two-step abdomino-parasacral resection of a giant pelvic lipoma: a case report
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1926-1932
.
(31 August 2024)
Spontaneous regression of advanced hepatocellular carcinoma following COVID-19 infection and vaccination: a case report and review of literature
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1933-1938
.
(31 August 2024)
The rare occurrence of unifocal peritoneal mesothelioma: a case report, literature review, and future directions
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1939-1947
.
(31 August 2024)
Corticosteroid-dependent immune checkpoint inhibitor-induced enterocolitis treated with vedolizumab: a case report
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1948-1956
.
(31 August 2024)
DNA signature and occult blood in stool led to diagnosis of an early-onset metastatic rectal cancer in a young pregnant woman: a case report
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1957-1961
.
(31 August 2024)
Response to hepatic arterial infusion chemotherapy combined with camrelizumab and targeted therapy in advanced primary hepatic neuroendocrine carcinoma: a case report and literature review
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1962-1972
.
(31 August 2024)
Case Report: iMDT Corner
Tumor complete response and pyogenic liver abscess secondary to concurrent microwave ablation plus atezolizumab and bevacizumab in liver cancer: a case report
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1973-1980
.
(31 August 2024)
Editorial Commentary
Transverse colon cancer: a call for focused research in an understudied heterogenous disease
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1981-1986
.
(31 August 2024)
PLK1 and its role in the evolving landscape of KRAS-mutated colorectal cancer
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1987-1992
.
(31 August 2024)
Gut microbiota modulation: the key to improving outcomes after colorectal cancer surgery?
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1993-1995
.
(31 August 2024)
Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer
Journal of Gastrointestinal Oncology
2024;
15
(4)
:1996-2001
.
(31 August 2024)
MRTX1133’s promise for treating KRASG12D-mutant pancreatic cancer
Journal of Gastrointestinal Oncology
2024;
15
(4)
:2002-2005
.
(31 August 2024)
Editorial
Another hammer, but we need a wrench, and a screwdriver—positron emission tomography/magnetic resonance imaging represents another tool for post-delivery 90Y dosimetry, but what are we still missing?
Journal of Gastrointestinal Oncology
2024;
15
(4)
:2006-2010
.
(31 August 2024)
PD-L1 expression in pancreaticobiliary adenosquamous carcinoma: a potential biomarker for immunotherapy
Journal of Gastrointestinal Oncology
2024;
15
(4)
:2011-2012
.
(31 August 2024)
Modern times call for modernized treatment strategies for advanced gastrointestinal stromal tumors
Journal of Gastrointestinal Oncology
2024;
15
(4)
:2013-2015
.
(31 August 2024)
Duodenal neuroendocrine tumors: how safe is endoscopic resection?
Journal of Gastrointestinal Oncology
2024;
15
(4)
:2016-2018
.
(31 August 2024)
Exploring the complexities of metachronous primary tumors after surgically managed pancreatic cancer—why lightning strikes twice
Journal of Gastrointestinal Oncology
2024;
15
(4)
:2019-2021
.
(31 August 2024)
Letter to the Editor
Effect of perioperative blood transfusion (BTF) on elderly gastric cancer patients
Journal of Gastrointestinal Oncology
2024;
15
(4)
:2022-2023
.
(31 August 2024)
Impact of perioperative blood transfusion on elderly gastric cancer patients
Journal of Gastrointestinal Oncology
2024;
15
(4)
:2024-2025
.
(31 August 2024)
Insights and recommendations for enhancing the prognostic nomogram in elderly patients with stage II–III colorectal cancer
Journal of Gastrointestinal Oncology
2024;
15
(4)
:2026-2027
.
(31 August 2024)
